This article has Open Peer Review reports available.
Predictors for vascular cognitive impairment in stroke patients
© The Author(s). 2016
Received: 1 December 2015
Accepted: 15 July 2016
Published: 26 July 2016
Around two thirds stroke patients may suffer from vascular cognitive impairment (VCI). Our previous study has validated the NINDS-CSN harmonization standard for VCI diagnosis in Chinese. In this study, we aimed to investigate the predictors for VCI in Chinese post-stroke patients.
We compared epidemiological, clinical, and neuroimaging data (number, size and location of acute infarcts and lacunes, severities of white matter hyperintensities and brain atrophy) between stroke patients with and without VCI. Univariate and logistic regression analyses were utilized to determine VCI predictors.
Fifty-six consecutive patients (age, 63.8 ± 8.3 years; female, 37.5 %) were recruited at a mean interval of 7.1 months after stroke onset, and 31 (55.4 %) patients were diagnosed with VCI based on a validated 60-min neuropsychological battery. VCI patients were older (p = 0.023), less educated (p = 0.001), more likely to be female (p < 0.001), had a recurrent stroke (p = 0.028), and described higher apathy (p = 0.022) and worse pre-stroke cognition (p = 0.048) than cognitively normal patients. Lower educational level (adjusted odds ratio [OR] 0.750, 95 % confidence interval [CI], 0.573–0.981; p = 0.035), female sex (adjusted OR 8.288, 95 % CI, 1.522–45.113; p = 0.014), recurrent stroke (adjusted OR 11.327, 95 % CI, 1.335–96.130, p = 0.026), and global cortical atrophy (adjusted OR 5.730, 95 % CI, 1.128–29.101, p = 0.035) were independently associated with VCI in post-stroke patients.
Lower education, female sex, recurrent stroke and global cortical atrophy were associated with VCI in Chinese stroke patients.
Stroke survivors are prone to develop cognitive impairment, with a frequency of 62.6 % at 3 months post-stroke , and persisted long-term functional effects . This prolonged cognitive sequela of stroke has been widely used to study vascular cognitive impairment (VCI). However, most studies have either focused on dementia , or used diverse diagnostic criteria with various cognitive scales . In 2006, the National Institute of Neurological Disorders and Stroke and Canadian Stroke Network (NINDS-CSN) established common standards for VCI assessments , and our previous work validated the Chinese adaption of neuropsychological scales in mild stroke patients .
VCI may result directly from an acute stroke or from underlying chronic brain lesions, such as white matter hyperintensities (WMHs) and subclinical lacunes . However, the predictors for VCI in post-stroke patients was equivocal [3, 8, 9]. In some studies, WMHs [3, 8], lacunes [10, 11], silent brain infarctions , and brain atrophy [3, 10] had been associated with VCI after stroke. However, others reported that large infarcts were associated with greater likelihood of cognitive dysfunction, but found no significant effect of WMHs, silent infarcts or cerebral atrophy in predicting post-stroke VCI , or had not found any significant association after multivariable adjustment [12, 14].
Although VCI used to be diagnosed only in the context of a cerebral infarction, recent studies have highlighted the importance of pre-existing brain lesions as a key determinant for incident VCI in post-stroke patients [3, 8]. Moreover, in the investigation of factors related to VCI development, few studies have applied a population-validated NINDS-CSN neuropsychological protocol to VCI diagnosis . To investigate the predictors for post-stroke VCI, we collected epidemiological, clinical and neuroimaging data in detail. We hypothesized that chronic brain lesions (e.g., old infarcts, WMHs, and brain atrophy) would be significant predictors of the development of VCI after stroke.
Participants were consecutive patients with an MRI scan for an acute ischemic stroke, aged 50 years or older, admitted to a teaching hospital from January to June 2013. Additional inclusion criteria for neuropsychological assessment were an available informant who was knowledgeable with the patient’s cognitive performance on a daily or next to daily basis for at least 10 years prior to recruitment, informed consent, and absence of severe motor and language disabilities hindering cognitive evaluation. Exclusion criteria for this study were a history of hemorrhagic stroke, traumatic brain injury, Parkinson disease, psychiatric disorders known to influence cognitive function, or a pre-existing cognitive impairment according to the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE), a screening instrument validated in Chinese, scoring 3.4 or more . The institutional review board at Jinling Hospital approved the study, and all participants provided written informed consent.
Patients’ cognitive and psychological status was assessed at 3 to 12 months after stroke, using the 60-min Chinese version of NINDS-CSN neuropsychological protocol. The protocol examined the following four cognitive domains: executive/activation (animal naming , WAIS-III Digit symbol-coding , trail making test, parts A and B ), language (modified Boston naming test ), visuoconstruction (Rey-Osterrieth Complex Figure Test [RCFT]-copy trial ), and memory (delayed recall on the revised Hopkins verbal learning test  and RCFT ). Besides, the Chinese version of Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA), Beijing version were evaluated to test global cognitive function; the Geriatric Depression Scale (GDS) and the Apathy Evaluation Scale (AES) were used to assess depressive and apathetic symptoms, respectively; the Neuropsychiatric Inventory Questionnaire (NIQ) was administered to probe behavioral domains; and the IQCODE was also completed by the informant to obtain the pre-morbid history of cognitive status. All neuropsychological tests were administered in each subject’s primary language of Mandarin Chinese. For each domain, cognitive impairment was identified if more than half of the tests had a score >1.5 SD below age and education matched means of controls . For example, the executive/activation domain consisted of 4 tests, and was classified as having an abnormal function if patients scored >1.5 SD below the means on at least 2 tests. The subject was categorized as a VCI patient when cognitive impairment was observed in at least one domain, and in the absence of pre-stroke cognitive impairment.
We retrospectively collected data on demographics and clinical factors regarding the index event from medical records. Basic information included age, sex, years of education, and body mass index. Vascular risk factors that we recorded included hypertension (defined as presenting with a history of hypertension, or under antihypertensive treatment), diabetes mellitus (defined by fasting plasma glucose ≥7.0 mmol/L, or 2-h postprandial glucose ≥11.1 mmol/L, or the use of insulin/oral hypoglycemic medication), hyperlipidemia (defined as total cholesterol ≥5.2 mmol/L, or low-density lipoprotein cholesterol ≥2.6 mmol/L, or triglyceride ≥1.70 mmol/L, or being treated with lipid-lowering drugs), atrial fibrillation (diagnosed according to electrocardiogram), ischemic heart disease (defined as a history of myocardial infarction or angina pectoris), recurrent stroke, smoking, and current alcohol use (drinking >2 units per day). In addition, stroke subtype (Trial of Org 10172 in Acute Stroke Treatment, TOAST criteria) and severity (National Institutes of Health Stroke Scale, NIHSS score) of stroke were also recorded.
Routine non-contrast brain computed tomography was initially performed. All patients underwent brain MRI on a 1.5-T or 3.0-T scanner (GE Healthcare, Milwaukee, WI, USA), including sequences of axial T1-weighted imaging (TR/TE = 350/2.5 ms), axial T2-weighted imaging (TR/TE = 4000/98 ms), diffusion-weighted imaging (DWI) (TR/TE = 3000/91 ms), and coronal T2 fluid-attenuated inversion recovery (FLAIR) (TR/TE = 8000/93 ms), with slice thickness 5 mm, spacing between slices 6.5 mm, field of view 90.625 mm for T1/T2-weighted imaging, 100 mm for DWI and 81.25 mm for FLAIR, and matrix of 320 × 260, 512 × 416, 256 × 256 and 512 × 464 for T1, T2-weighted imaging, DWI and FLAIR, accordingly. All MRI images were read by X. C. who was blinded to subjects’ clinical or neuropsychological information.
The assessment of acute and chronic brain lesions were based on MRI. An acute infarction was defined as a lesion that showed DWI hyperintensity with corresponding apparent diffusion coefficient hypointensity . Acute ischemic characteristics with regard to infarct number, size and location were collected. Lesion size was recorded in maximum axial diameter by using the built-in software Numaris/4 (syngo MR B17; Siemens). Lesion locations were classified as frontal lobe, parieto-occipital lobe, temporal lobe, basal ganglia, thalamus or the infratentorial area. WMHs were visually rated on T2-weighted and FLAIR images using the age-related white matter change (ARWMC) scale . Large and small old infarcts evident on MRI were recorded. Small old infarcts, termed as lacunes, were CSF-like lesions of between 3 mm and 15 mm in diameter, with a surrounding rim of hyperintensity on FLAIR and T1-weighted images . Brain atrophy was estimated by a 4-point rating scale for the assessment of global cortical atrophy (GCA) , and a 5-point rating scale for medial temporal lobe atrophy (MTA) , with GCA being defined as 1 point or more and MTA ≥2 points. The presence of cerebral artery stenosis was determined by magnetic resonance angiography, computed tomography angiography, or digital subtraction angiography.
To test intra-rater agreement of the neuroimaging evaluation, 10 randomly selected scans were re-read by the same rater (X. C.), blinded to previous rating scores. The intra-rater agreement was then assessed using intraclass correlation coefficients (ICC).
Descriptive statistics were calculated for demographics, clinical, and neuroimaging variables in patients with and without VCI. Group comparisons of categorical variables were performed with the χ2 test, and comparisons of continuous variables were done by the independent sample t test, or Mann–Whitney U test in case of skewed distributions. Effect sizes were estimated in a common form of Cohen’s d, and the intervals for Cohen’s d were: 0–0.1, no effect; 0.2–0.4, small effect; 0.5–0.7, intermediate effect; 0.8 and higher: strong effect . Variables that were important risk factors for VCI based on prior knowledge, except those highly correlated, were introduced as independent variables in multivariate stepwise logistic regression analysis. p < 0.05 indicated statistical significance. All analyses were performed using the SPSS Statistics for Windows, version 17.0.
Between January and June 2013, 165 stroke patients with MRI scans were screened, of whom 56 patients underwent neuropsychological assessments (mean age, 63.8 ± 8.3 years, 37.5 % were women). Median NIHSS score on admission was 3 (interquartile range [IQR], 1–5.75). The interval between stroke onset and cognitive assessment was 7.1 months (SD = 2.3), while the interval between MRI examination and cognitive assessment was 6.9 months (SD = 2.3). Comparisons were made between patients with (n = 31, 55.4 %) and without (n = 25, 44.6 %) VCI.
Clinical characteristics comparing patients with and without VCI after stroke
Patients without VCI (n = 25)
Patients with VCI (n = 31)
61.0 ± 6.9
66.0 ± 8.8
3 (12.0 %)
18 (58.1 %)
11.2 ± 3.7
7.5 ± 4.3
Body mass index (kg/m2)a
24.8 ± 2.3
25.6 ± 4.0
Vascular risk factors
19 (76.0 %)
27 (87.1 %)
10 (40.0 %)
13 (41.9 %)
19 (76.0 %)
22 (71.0 %)
1 (4.0 %)
1 (3.2 %)
Ischemic heart diseaseb
4 (16.0 %)
2 (6.5 %)
16 (64.0 %)
13 (41.9 %)
7 (28.0 %)
3 (9.7 %)
2 (8.0 %)
10 (32.3 %)
Stroke subtype by TOAST
10 (40.0 %)
17 (54.8 %)
10 (40.0 %)
11 (35.5 %)
1 (4.0 %)
1 (3.2 %)
4 (16.0 %)
2 (6.5 %)
3.2 ± 3.2
4.4 ± 3.7
Onset-to-test time (months)a
6.7 ± 2.3
7.4 ± 2.4
Comparison of neuropsychological assessments between patients with and without VCI after stroke
Patients without VCI (n = 26)
Patients with VCI (n = 31)
16.0 ± 3.8
11.6 ± 4.2
WAIS-III Digit symbol-codinga
20.6 ± 4.5
10.8 ± 5.8
TMT A time (sec)a
43.4 ± 9.8
111.5 ± 74.2
TMT B time (sec)a
104.5 ± 31.0
200.7 ± 78.4
11.4 ± 2.1
8.2 ± 2.4
34.7 ± 1.2
28.1 ± 7.0
HVLT-R delayed recalla
7.0 ± 2.3
3.3 ± 2.1
RCFT delayed recalla
19.0 ± 4.7
9.8 ± 7.3
28.1 ± 1.3
24.6 ± 3.2
22.7 ± 3.2
16.4 ± 4.4
2.7 ± 1.9
3.9 ± 4.1
59.4 ± 5.7
54.4 ± 9.3
Comparison of neuroimaging features between patients with and without VCI after stroke
Patients without VCI (n = 25)
Patients with VCI (n = 31)
Patients with acute lesiona
24 (96.0 %)
31 (100.0 %)
No. of acute lesionsb
Lesion size (mm)c
19.0 ± 11.3
26.0 ± 20.5
Chronic brain changes
Patients with large old infarcta
1 (4.0 %)
6 (19.4 %)
Patients with lacunesa
18 (72.0 %)
25 (80.6 %)
No. of lacunesc
3.0 ± 3.3
4.4 ± 4.2
Lacunar size (mm)c
5.7 ± 4.3
7.6 ± 4.48
ARWMC total scorec
5.6 ± 3.8
6.6 ± 4.0
Presence of MTAa,d
5 (20.0 %)
4 (12.9 %)
Presence of GCAa,e
7 (28.0 %)
15 (48.4 %)
6 (24.0 %)
4 (12.9 %)
12 (48.0 %)
20 (64.5 %)
7 (28.0 %)
5 (16.1 %)
2 (6.5 %)
6 (24.0 %)
4 (12.9 %)
Mild stenosis (0–50 %)a
7 (28.0 %)
7 (22.6 %)
Moderate stenosis (50 %–70 %)a
2 (8.0 %)
6 (19.4 %)
Severe stenosis (70–99 %)a
2 (8.0 %)
9 (29.0 %)
8 (32.0 %)
5 (16.1 %)
Risk factors associated with VCI in multivariate logistic regression
95 % Confidence interval
Presence of GCA
This study suggested that risk factors for VCI in post-stroke patients included lower education, female sex, recurrent stroke and global cortical atrophy.
Stroke serves as an important factor in VCI. In our study, 55.4 % of the stroke patients suffered VCI, which was lower than that (62.6 %) of a recent study in Korea . However, participants in our study had a longer interval between neuropsychological tests and stroke (7.1 months vs. 3 months), which could possibly allow stroke recovery. Evaluations took place 3 to 12 months after stroke onset. Therefore, some participants were further along in their recovery than others. While onset-to-test time did not vary between patients with and without VCI, a long time span may have reduced the sensitivity of the neuropsychological tests.
Recurrent stroke was an independent risk factor for VCI in our study, paralleling previous findings that recurrent stroke would at least double the rates of dementia than first-ever stroke . The underlying mechanism may be that an increased volume of brain injury would reduce the threshold for manifestation of subclinical neurodegenerative disorders. Compared with cognitively normal patients, VCI patients tended to show a larger infarct size with a medium effect size of the differences. Earlier studies had generally shown an inconsistent relationship between size and number of infarcts and cognitive impairment [3, 13], this could possibly be explained by the uncertainty of cortical involvement, and differences in distribution of hypoperfusion . Though cortical involvement was considered to be associated with more impaired cognitive function , the scientific evidence for it was rare and conflicting. One recent studies showed a comparable performance between cortical and subcortical infarctions , and our study did not show between-group differences regarding lesion locations as well. Nevertheless, these findings were based on a cross-sectional design, and how the change of an acute lesion over time could affect cognitive progression could be further explored.
The role of chronic brain lesions on the development of post-stroke VCI was substantial . Patients with lacunes have been reported to have poorer performance in multiple cognitive domains and steeper decline in cognitive function in different cohorts, such as the Cardiovascular Health Study, the Rotterdam Study and the Epidemiology of Dementia in Singapore study [10–12]. Our study likewise indicated a trend of association between lacunar size and VCI. The possible explanation was that an increase in lacunar volume was associated with decline in executive function , besides, it was demonstrated that the silent lacunar infarct was related to cortical atrophy, which may also impair cognition . Recent surveys underlined the importance of WMHs, MTA as independent risk factors for VCI after stroke [3, 8], but in this study, VCI patients did not show an association with WMHs or MTA. This might be due to the exclusion of patients with pre-stroke cognitive impairment in our study; for individuals with more severe WMHs and more atrophy are prone to display a worsening of cognitive ability, which could account for their apparent associations with post-stroke VCI . Severe WMHs were mainly associated with frontal lobe dysfunction, which was considered to be a consequence of damaged neural transmission and interneural connection, however, novel evidence implicated that the effects of WMHs on cognitive performance might be mediated by cortical thickness . Therefore, in some reports, more extensive WMHs were shown to be related to cognitive impairment, but the association did not persist in multivariate modeling [12, 14]. Another study from Finland also suggested a loss of significance for the correlation between MTA and post-stroke dementia after excluding individuals with pre-stroke dementia .
In this study, female sex and education were independently associated with VCI in post-stroke patients, concurring with previous findings [33, 34]. Female sex may play a role in poststroke cognitive impairment by related degenerative pathology, which would interact with vascular pathology as well , and unsurprisingly, greater prestroke cognitive decline was observed in VCI patients in our study. The beneficial effect of education could be that a higher education level indicated better cognitive reserve, in this way, patients with higher reserve would show an altered, compensatory network to maintain function in the face of age-related pathophysiological changes .
Various definitions of VCI would hinder its identification. Based on the common standards proposed by the NINDS-CSN, our study may be one of the first studies using population validated criteria for VCI diagnosis [1, 5]. Besides, this study will in part contribute to a future meta-analysis on the subject whether patients with cognitive impairment were associated with direct infarct lesions, or the underlying chronic brain lesions.
Limitations of the study were as follows. First, this was a single-center study, the sample size was small and was heterogeneous with regard to age, stroke subtype, and cognitive status, limiting the statistical power, and increasing the possibility of type II errors. Thus, null findings with meaningful effect sizes such as larger size of acute infarct and lacunes, and cortical atrophy, may be negatively affected due to low statistical power. Second, the study sample was hospital-based and most patients suffered a relatively mild stroke, so our results may not generalize to those with more severe or very mild stroke, or to those who show specific cognitive deficits (e.g., aphasia) that precluded proper cognitive assessment. Third, pre-stroke cognitive status was merely measured by IQCODE due to the cross-sectional nature, hence patients with subtle cognitive impairment may be included. Fourth, both 1.5 T and 3.0 T MRIs were used, which could introduce magnetic bias for their sensitivity to lesions may be different. Fifth, we measured MTA, GCA and WMHs using visual rating scale, and lacunes by size and number rather than quantitative calculation, further larger, multi-center studies that use automated unbiased measurements are needed to confirm the observations in the present study.
In conclusion, lower education, female sex and recurrent stroke were predictors for VCI in Chinese post-stroke patients. Chronic brain lesions such as lacunes and cortical atrophy might be potential imaging biomarkers of VCI, which could be examined in future studies. In addition, effort should be made to optimize secondary stroke prevention and to increase cognitive reserve, for the purpose of delaying the clinical expression of VCI. Further preclinical studies are warranted to investigate the underlying pathogenesis as well as targeted interventions in long term VCI prevention and treatment.
AES, apathy evaluation scale; ARWMC, age-related white matter change; FLAIR, fluid-attenuated inversion recovery; GCA, global cortical atrophy; GDS, Geriatric depression scale; ICC, intraclass correlation coefficients; IQCODE, the informant questionnaire on cognitive decline in the elderly; MMSE, mini-mental state examination; MoCA, montreal cognitive assessment; MTA, medial temporal lobe atrophy; NINDS-CSN, National Institute of Neurological Disorders and Stroke and Canadian Stroke Network; NIQ, neuropsychiatric inventory questionnaire; OR, odds ratio; RCFT, Rey-Osterrieth complex figure test; TOAST, trial of org 10172 in acute stroke treatment; VCI, vascular cognitive impairment; WMH, white matter hyperintensities
We thank Dr. Shelley Peery and the Research and Editing Consulting Program for their help in English language editing.
This work was supported by National Natural Science Foundation of China (Grant Number: 81201078, 81300244 and 81400898).
Availability of data and materials
Original data will be supplied to other researchers upon request and after local ethical amendment.
XC acquired and interpreted data and drafted the manuscript. LD participated in the design of the study and performed the statistical analysis. YH helped to draft the manuscript. LT, QD and YL recruited stroke patients. SW helped to draft the manuscript. YX designed the study and critically revised the manuscript. XL has given final approval of the version to be published. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
The institutional review board at Jinling Hospital approved the study. All participants provided written informed consent.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Yu KH, Cho SJ, Oh MS, Jung S, Lee JH, Shin JH, Koh IS, Cha JK, Park JM, Bae HJ, et al. Cognitive Impairment Evaluated With Vascular Cognitive Impairment Harmonization Standards in a Multicenter Prospective Stroke Cohort in Korea. Stroke. 2013;44:786–8. doi:10.1161/strokeaha.112.668343/-/dc1.View ArticlePubMedGoogle Scholar
- Douiri A, Rudd AG, Wolfe CD. Prevalence of poststroke cognitive impairment: South London Stroke Register 1995–2010. Stroke. 2013;44(1):138–45. doi:10.1161/STROKEAHA.112.670844.View ArticlePubMedGoogle Scholar
- Yang J, Wong A, Wang Z, Liu W, Au L, Xiong Y, Chu WW, Leung EY, Chen S, Lau C, et al. Risk factors for incident dementia after stroke and transient ischemic attack. Alzheimer’s Dementia J Alzheimer’s Assoc. 2014. doi:10.1016/j.jalz.2014.01.003.Google Scholar
- McDonnell MN, Bryan J, Smith AE, Esterman AJ. Assessing cognitive impairment following stroke. J Clin Exp Neuropsychol. 2011;33(9):945–53. doi:10.1080/13803395.2011.575769.View ArticlePubMedGoogle Scholar
- Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, Powers WJ, DeCarli C, Merino JG, Kalaria RN, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37(9):2220–41. doi:10.1161/01.STR.0000237236.88823.47.View ArticlePubMedGoogle Scholar
- Chen XL, Wong A, Ye RD, Xiao LL, Wang ZJ, Lin Y, Yang F, Li H, Feng T, Duan LH et al.: Validation of NINDS-CSN neuropsychological battery for vascular cognitive impairment in Chinese stroke patients. BMC Neurol 2015, 15(20). doi: 10.1186/s12883-015-0270-z.Google Scholar
- Gottesman RF, Hillis AE. Predictors and assessment of cognitive dysfunction resulting from ischaemic stroke. Lancet Neurol. 2010;9(9):895–905. doi:10.1016/s1474-4422(10)70164-2.View ArticlePubMedPubMed CentralGoogle Scholar
- Poh YY, Poh YQJ, Ng A, Marmin M, Ho YL, Zainal H, Kandiah N: Burden of Silent Cerebrovascular Disease and Not Acute Infarct Characteristics Determine Post-Stroke Cognitive Impairment, Both in Small Vessel and Large Vessel Strokes. Neurology 2014, 82(10 Supplement):P5.222. doi, http://www.neurology.org/content/82/10_Supplement/P5.222
- Jaillard A, Grand S, Le Bas JF, Hommel M. Predicting cognitive dysfunctioning in nondemented patients early after stroke. Cerebrovasc Dis. 2010;29(5):415–23. doi:10.1159/000289344.View ArticlePubMedGoogle Scholar
- Thong JY, Hilal S, Wang Y, Soon HW, Dong Y, Collinson SL, Anh TT, Ikram MK, Wong TY, Venketasubramanian N, et al. Association of silent lacunar infarct with brain atrophy and cognitive impairment. J Neurol Neurosurg Psychiatry. 2013;84(11):1219–25. doi:10.1136/jnnp-2013-305310.View ArticlePubMedGoogle Scholar
- Longstreth WT, Bernick C, Manolio TA, Bryan N, Jungreis CA, Price TR. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol. 1998;55:1217–25. doi:10.1001/archneur.55.9.1217.View ArticlePubMedGoogle Scholar
- Vermeer SE, Prins ND, Den Heijer T, Hofman A, Koudstaal PJ, Breteler MMB. Silent brain infarcts and the risk of dementia and cognitive decline: the Rotterdam Scan study. N Engl J Med. 2003;348:1215–22. doi:10.1056/NEJMoa022066.View ArticlePubMedGoogle Scholar
- Nys GMS, van Zandvoort MJE, de Kort PLM, Jansen BPW, de Haan EHF, Kappelle LJ. Cognitive Disorders in Acute Stroke: Prevalence and Clinical Determinants. Cerebrovasc Dis. 2007;23(5–6):408–16. doi:10.1159/000101464.View ArticlePubMedGoogle Scholar
- Jokinen H, Kalska H, Mantyla R, Ylikoski R, Hietanen M, Pohjasvaara T, Kaste M, Erkinjuntti T. White matter hyperintensities as a predictor of neuropsychological deficits post-stroke. J Neurol Neurosurg Psychiatry. 2005;76(9):1229–33. doi:10.1136/jnnp.2004.055657.View ArticlePubMedPubMed CentralGoogle Scholar
- Fuh JL, Teng EL, Lin KN, Larson EB, Wang SJ, Liu CY, Chou P, Kuo BIT, Liu HC. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a screening tool for dementia for a predominantly illiterate Chinese population. Neurology. 1995;45:92–6. doi:10.1212/WNL.45.1.92.View ArticlePubMedGoogle Scholar
- Isaacs B, Kennie AT. The Set Test as an Aid to the Detection of Dementia in Old People. Br J Psychiatry. 1973;123(4):467–70. doi:10.1192/bjp.123.4.467.View ArticlePubMedGoogle Scholar
- Wechsler D. WAIS-III Administration and Scoring Manual. New York: The Psychological Corporation; 1997. doi.Google Scholar
- Reitan RM. Validity of the Trail Making Test as an Indicator of Organic Brain Damage. Percept Mot Skills. 1958;8:271–6. doi:10.2466/PMS.8.7.271-276.View ArticleGoogle Scholar
- Franzen MD, Haut MW, Rankin E, Keefover R. Empirical comparison of alternate forms of the Boston Naming Test. Clin Neuropsychol. 1995;9(3):225–9. doi:10.1080/13854049508400484.View ArticleGoogle Scholar
- Corwin J, Bylsma FW. Psychological examination of traumatic encephalopathy. Clin Neuropsychol. 1993;7(1):3–21. doi:10.1080/13854049308401883.View ArticleGoogle Scholar
- Benedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins Verbal Learning Test ? Revised: Normative Data and Analysis of Inter-Form and Test-Retest Reliability. Clin Neuropsychol (Neuropsychol Dev Cognition Section D). 1998;12(1):43–55. doi:10.1076/clin.18.104.22.1686.Google Scholar
- van Everdingen KJ, van der Grond J, Kappelle LJ, Ramos LMP, Mali WPTM. Diffusion-Weighted Magnetic Resonance Imaging in Acute Stroke. Stroke. 1998;29(9):1783–90. doi:10.1161/01.str.29.9.1783.View ArticlePubMedGoogle Scholar
- Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjogren M, Wallin A, Ader H, Leys D, Pantoni L, et al. A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT. Stroke. 2001;32(6):1318–22. doi:10.1161/01.str.32.6.1318.View ArticlePubMedGoogle Scholar
- Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O’Brien JT, Barkhof F, Benavente OR, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–38. doi:10.1016/s1474-4422(13)70124-8.View ArticlePubMedPubMed CentralGoogle Scholar
- Pasquier F, Leys D, Weerts J, Mounier-Vehier F, Barkhof F, Scheltens P. Inter-and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol. 1996;36(5):268–72. doi:10.1159/000117270.View ArticlePubMedGoogle Scholar
- Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55(10):967–72. doi:10.1136/jnnp-2012-302562.View ArticlePubMedPubMed CentralGoogle Scholar
- Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawence Erlbaum; 1988. p. 281–5. doi.Google Scholar
- Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8:1006–18. doi:10.1016/s14744422(09)70236-4.View ArticlePubMedGoogle Scholar
- Turunen KE, Kauranen TV, Laari SP, Mustanoja SM, Tatlisumak T, Poutiainen ET. Cognitive deficits after subcortical infarction are comparable with deficits after cortical infarction. Eur J Neurol Off J Eur Federation Neurol Soc. 2013;20(2):286–92. doi:10.1111/j.1468-1331.2012.03844.x.Google Scholar
- Mungas D, Harvey D, Reed B, Jagust W, DeCarli C, Beckett L, Mack W, Kramer J, Weiner M, Schuff N. Longitudinal volumetric MRI change and rate of cognitive decline. Neurology. 2005;65(4):565–71. doi:10.1212/01.wnl.0000172913.88973.0d.View ArticlePubMedPubMed CentralGoogle Scholar
- Tuladhar AM, Reid AT, Shumskaya E, de Laat KF, van Norden AG, van Dijk EJ, Norris DG, de Leeuw FE. Relationship between white matter hyperintensities, cortical thickness, and cognition. Stroke. 2015;46(2):425–32. doi:10.1161/STROKEAHA.114.007146.View ArticlePubMedGoogle Scholar
- Pohjasvaara T, Mantyla R, Salonen O, Aronen HJ, Ylikoski R, Hietanen M, Kaste M, Erkinjuntti T. How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch Neurol. 2000;57:1295–300. doi:10.1001/archneur.57.9.1295.View ArticlePubMedGoogle Scholar
- Jacquin A, Binquet C, Rouaud O, Graule-Petot A, Daubail B, Osseby G-V, Bonithon-Kopp C, Giroud M, Béjot Y. Post-Stroke Cognitive Impairment: High Prevalence and Determining Factors in a Cohort of Mild Stroke. J Alzheimers Dis. 2014;40(4):1029–38. doi:10.3233/JAD-131580.PubMedGoogle Scholar
- Tang WK, Chan SS, Chiu HF, Ungvari GS, Wong KS, Kwok TC, Mok V, Wong KT, Richards PS, Ahuja AT. Frequency and clinical determinants of poststroke cognitive impairment in nondemented stroke patients. J Geriatr Psychiatry Neurol. 2006;19(2):65–71. doi:10.1177/0891988706286230.View ArticlePubMedGoogle Scholar
- Pendlebury ST. Dementia in patients hospitalized with stroke: rates, time course, and clinico-pathologic factors. Int J Stroke Off J Int Stroke Soc. 2012;7(7):570–81. doi:10.1111/j.1747-4949.2012.00837.x.View ArticleGoogle Scholar
- Duda B, Puente AN, Miller LS. Cognitive reserve moderates relation between global cognition and functional status in older adults. J Clin Exp Neuropsychol. 2014;36(4):368–78. doi:10.1080/13803395.2014.892916.View ArticlePubMedGoogle Scholar